Home/Filings/4/0001209191-22-010054
4//SEC Filing

Stewart Christopher P. 4

Accession 0001209191-22-010054

CIK 0001411690other

Filed

Feb 14, 7:00 PM ET

Accepted

Feb 15, 9:08 PM ET

Size

5.8 KB

Accession

0001209191-22-010054

Insider Transaction Report

Form 4
Period: 2022-02-15
Stewart Christopher P.
Chief Financial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-15+550,000550,000 total
    Exercise: $2.18Exp: 2032-02-14Common Stock (550,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option shall vest monthly over 48 months beginning on the one-month anniversary of February 15, 2022 (the "Grant Date") such that the option shall be fully vested and exercisable on the four-year anniversary of the Grant Date.

Issuer

Bionano Genomics, Inc.

CIK 0001411690

Entity typeother

Related Parties

1
  • filerCIK 0001822991

Filing Metadata

Form type
4
Filed
Feb 14, 7:00 PM ET
Accepted
Feb 15, 9:08 PM ET
Size
5.8 KB